000640.KO Donga Socio Holdings

Healthcare Pharmaceuticals Korea Stock Exchange
88,300 KRW
Close of Nov 5, 2026
73,890 119,691
Market cap
KRW 594B
P/E
6.9x
P/B
0.49x
ROE
8.3%
Dividend yield
1.81%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 000640.KO undervalued?

Graham number
Price88,300
Graham value226,809
Discount61.1%

000640.KO trades 61.1% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Donga Socio Holdings fundamental analysis

No fundamental analysis for Donga Socio Holdings yet.

Donga Socio Holdings stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Donga Socio Holdings

Dong-A Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through a Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of Stelara in Phase 3 clinical trial; DA-1241 in Phase 2 clinical trial for the tre…

Full company profile